Lv1
10 积分 2025-03-08 加入
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas
3小时前
待确认
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study
3小时前
求助中
The Biology of MZL subtypes: Challenge and Relevance of Classification
7个月前
已关闭
The Treatment of Marginal Zone Lymphoma
7个月前
已完结
皖公网安备34019202002308
